Discontinuation report NORMOSOL-R
| Report ID | 208273 |
| Drug Identification Number | 00039500 |
| Brand name | NORMOSOL-R |
| Common or Proper name | Multiple Electrolytes Injection Type 1 USP |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM GLUCONATE SODIUM ACETATE SODIUM CHLORIDE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE |
| Strength(s) | 0.502G 0.222G 0.526G 0.014G 0.037G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000 mL |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-02-28 |
| Actual discontinuation date | |
| Remaining supply date | 2025-02-28 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Last lot expires 28-Feb-2025 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-10-27 | French | Compare |
| v3 | 2023-10-27 | English | Compare |
| v2 | 2023-10-26 | French | Compare |
| v1 | 2023-10-26 | English | Compare |
Showing 1 to 4 of 4